Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market: A Significant Driver Propelling The Quit Smoking Drugs Market In 2025

The Quit Smoking Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Quit Smoking Drugs Market Size During the Forecast Period?
The market size for anti-smoking drugs has seen rapid expansion in the past few years. This market, projected to rise from $39.26 billion in 2024 to $44.62 billion in 2025, boasts a compound annual growth rate (CAGR) of 13.7%. The remarkable growth in the historic period is a result of health consciousness campaigns, advancements in medicine, government driven initiatives, incorporation of behavioral therapies, and shifts in consumer attitudes.

The market size for quit smoking drugs is anticipated to experience swift expansion in the upcoming years, reaching $79.99 billion in 2029 with a compound annual growth rate (CAGR) of 15.7%. This projected growth during the forecast period is due to the investment in research and development, rising demand for cessation aids, targeted marketing and awareness initiatives, and progress in pharmacotherapy. Notable trends for this period include tailored treatment methods, heightened awareness of health, digital therapies and applications, inclusion of behavioral therapy, along with targeted marketing and educational efforts.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9247

What Are the Major Segments in the Quit Smoking Drugs Market?
The quit smoking drugs market covered in this report is segmented -

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets
2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs
3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

Subsegments:
1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)
2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems
3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers
4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges
5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9247&type=smp

What Are The Driving Quit Smoking Drugs Market Evolution?
The escalating rate of smoking addiction is anticipated to fuel the expansion of the quit-smoking drug market in the future. Smoking involves the inhalation and exhalation of vapors from burning plant substances such as tobacco, marijuana, hashish, among others. Drugs designed to help individuals quit smoking are designed to lessen the desire for smoking by impeding the tobacco craving in a person. These medications are typically prescribed to manage nicotine withdrawal symptoms, enabling the person to quit smoking effectively. For instance, in July 2022, Statistics Canada, a governmental agency in Canada, reported that cigarette production saw a 5.8% increase compared to June 2021. Additionally, the total sales of cigarettes grew by 1.3% from May 2022, reaching 1.4 billion in June 2022. Thus, the rising prevalence of smoking addiction is boosting the growth of the quit-smoking drug market.

Which Firms Dominate The Quit Smoking Drugs Market Segments?
Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.

What Trends Are Expected to Dominate the Quit Smoking Drugs Market in the Next 5 Years?
Product enhancements are a major trend in the quit smoking drugs sector, leading to their increased popularity. Large-scale companies in this market are honing in on product innovation to further solidify their standing. A recent example is from August 2022 when Swedish Match AB, a well-known tobacco firm from Sweden, introduced ZYN Tobacco Gold, a nicotine pouch that tastes like tobacco and is marketed for use during travel. The product comes in medium (3 mg) and strong (6 mg) concentrations. Its rich, sweet tobacco taste, evocative of dry fruit, wood, and caramel, is favored by consumers as tobacco has become the preferred flavor to aid individuals in choosing healthier alternatives that are devoid of both tobacco and smoke. It's ideal for cigarette smokers looking to avoid tobacco intake while still enjoying a nicotine rush in smoke-free settings.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/quit-smoking-drugs-global-market-report

Which Is The Largest Region In The Quit Smoking Drugs Market?
North America was the largest region in the quit smoking drugs market in 2024. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Quit Smoking Drugs Market?
2. What is the CAGR expected in the Quit Smoking Drugs Market?
3. What Are the Key Innovations Transforming the Quit Smoking Drugs Industry?
4. Which Region Is Leading the Quit Smoking Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.